RCA
TMO icon

Resonant Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Resonant Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15M Buy
2,289
+143
+7% +$68.6K 0.05% 176
2026
Q1 		$1.06M Buy
2,146
+205
+11% +$111K 0.06% 171
2025
Q4 		$1.13M Buy
1,941
+89
+5% +$50.3K 0.06% 162
2025
Q3 		$899K Buy
1,852
+277
+18% +$129K 0.05% 175
2025
Q2 		$639K Buy
1,575
+132
+9% +$55.2K 0.04% 210
2025
Q1 		$719K Buy
1,443
+36
+3% +$19.5K 0.05% 172
2024
Q4 		$733K Sell
1,407
-437
-24% -$240K 0.05% 172
2024
Q3 		$1.14M Sell
1,844
-25
-1% -$14.8K 0.08% 142
2024
Q2 		$1.03M Buy
1,869
+227
+14% +$130K 0.08% 136
2024
Q1 		$955K Buy
1,642
+538
+49% +$302K 0.08% 149
2023
Q4 		$586K Sell
1,104
-301
-21% -$146K 0.06% 173
2023
Q3 		$712K Buy
1,405
+464
+49% +$247K 0.08% 146
2023
Q2 		$491K Sell
941
-180
-16% -$97.1K 0.05% 170
2023
Q1 		$647K Sell
1,121
-135
-11% -$76.1K 0.07% 152
2022
Q4 		$692K Buy
1,256
+114
+10% +$60.4K 0.09% 139
2022
Q3 		$580K Buy
1,142
+12
+1% +$6.72K 0.09% 137
2022
Q2 		$614K Buy
1,130
+101
+10% +$55.6K 0.1% 132
2022
Q1 		$610K Buy
1,029
+45
+5% +$25.9K 0.09% 128
2021
Q4 		$657K Sell
984
-92
-9% -$57.4K 0.1% 116
2021
Q3 		$615K Buy
1,076
+50
+5% +$27.4K 0.11% 109
2021
Q2 		$518K Buy
1,026
+26
+3% +$12.3K 0.1% 108
2021
Q1 		$457K Sell
1,000
-285
-22% -$136K 0.09% 113
2020
Q4 		$599K Sell
1,285
-215
-14% -$101K 0.14% 96
2020
Q3 		$663K Sell
1,500
-23
-2% -$9.5K 0.19% 86
2020
Q2 		$552K Sell
1,523
-460
-23% -$154K 0.16% 101
2020
Q1 		$562K Sell
1,983
-130
-6% -$41K 0.2% 117
2019
Q4 		$686K Buy
+2,113
New +$641K 0.22% 120

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Resonant Capital Advisors's TMO Position: Q2 2026 in Review

Resonant Capital Advisors increased its Thermo Fisher Scientific (TMO) stake by 6.7% in Q2 2026, buying an estimated $68.6K and bringing the position to 2,289 shares worth $1.15M. The position accounts for 0.05% of the portfolio, ranked #176.

Resonant Capital Advisors first reported a position in TMO in Q4 2019 and has held it in 27 quarters since. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Resonant Capital Advisors held 2,289 shares of Thermo Fisher Scientific worth $1.15M as of Q2 2026.
  • Resonant Capital Advisors bought 143 Thermo Fisher Scientific shares in Q2 2026, an estimated $68.6K.
  • Thermo Fisher Scientific made up 0.05% of Resonant Capital Advisors's portfolio in Q2 2026, its #176 holding.
  • Resonant Capital Advisors first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 27 quarters since.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Resonant Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.